Logo image of CUR

NEURALSTEM INC (CUR) Stock Price, Quote, News and Overview

NYSEARCA:CUR - NYSE Arca - US64127R3021

1.52  -0.31 (-16.94%)

After market: 1.58 +0.06 (+3.95%)

CUR Quote, Performance and Key Statistics

NEURALSTEM INC

NYSEARCA:CUR (10/31/2019, 8:00:00 PM)

After market: 1.58 +0.06 (+3.95%)

1.52

-0.31 (-16.94%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High13.78
52 Week Low1.1
Market Cap3.19M
Shares2.10M
Float687.15K
Yearly Dividend0
Dividend Yield0%
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A N/A


CUR short term performance overview.The bars show the price performance of CUR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60 -80

CUR long term performance overview.The bars show the price performance of CUR in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of CUR is 1.52 null. In the past month the price increased by 4.83%. In the past year, price decreased by -86.43%.

NEURALSTEM INC / CUR Daily stock chart

About CUR

Company Profile

NEURALSTEM's patent-protected technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The Company expects that its first Investigational New Drug application will be for the treatment of Ischemic Paraplegia, a form of paraplegia that sometimes results from the surgery to repair aortic aneurysms and for which there is no effective treatment.

Company Info

NEURALSTEM INC

20271 Goldenrod Lane

Germantown MD 20876

CEO: Kenneth Carter

Phone: 301-366-4841

NEURALSTEM INC / CUR FAQ

What is the stock price of NEURALSTEM INC today?

The current stock price of CUR is 1.52 null. The price decreased by -16.94% in the last trading session.


What is the ticker symbol for NEURALSTEM INC stock?

The exchange symbol of NEURALSTEM INC is CUR and it is listed on the NYSE Arca exchange.


On which exchange is CUR stock listed?

CUR stock is listed on the NYSE Arca exchange.


What is NEURALSTEM INC worth?

NEURALSTEM INC (CUR) has a market capitalization of 3.19M null. This makes CUR a Nano Cap stock.


What are the support and resistance levels for NEURALSTEM INC (CUR) stock?

NEURALSTEM INC (CUR) has a resistance level at 1.53. Check the full technical report for a detailed analysis of CUR support and resistance levels.


Should I buy NEURALSTEM INC (CUR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NEURALSTEM INC (CUR) stock pay dividends?

CUR does not pay a dividend.


What is the Price/Earnings (PE) ratio of NEURALSTEM INC (CUR)?

NEURALSTEM INC (CUR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.37).


CUR Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to CUR. When comparing the yearly performance of all stocks, CUR is a bad performer in the overall market: 97.87% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CUR Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to CUR. CUR has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CUR Financial Highlights

Over the last trailing twelve months CUR reported a non-GAAP Earnings per Share(EPS) of -5.37. The EPS decreased by -858.93% compared to the year before.


Industry RankSector Rank
PM (TTM) -43516.23%
ROA -190.29%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-3525%
Sales Q2Q%-96.87%
EPS 1Y (TTM)-858.93%
Revenue 1Y (TTM)-96.98%

CUR Ownership and Analysts


Ownership
Inst Owners38.3%
Ins Owners143.27%
Short Float %N/A
Short RatioN/A
Analysts
Analysts0
Price TargetN/A
EPS Next Y-100%
Revenue Next YearN/A